NCT00003816 arm group 05587c993ff624d17afe05491c617f4c [clinicaltrials_resource:NCT00003816/arm-group/05587c993ff624d17afe05491c617f4c]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003816 arm group 05587c993ff624d17afe05491c617f4c [clinicaltrials_resource:NCT00003816/arm-group/05587c993ff624d17afe05491c617f4c]
Bio2RDF identifier
NCT00003816/arm-group/05587c993ff624d17afe05491c617f4c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 587c993ff624d17afe05491c617f4c
description [clinicaltrials_vocabulary:description]
Patients receive cyclophospham ...... er 4-8 hours on days -3 to -1.
identifier
clinicaltrials_resource:NCT00003816/arm-group/05587c993ff624d17afe05491c617f4c
title
NCT00003816 arm group 05587c993ff624d17afe05491c617f4c
@en
type
label
NCT00003816 arm group 05587c99 ...... 87c993ff624d17afe05491c617f4c]
@en